|
Status |
Public on Apr 12, 2012 |
Title |
D106 |
Sample type |
RNA |
|
|
Source name |
ovarian tissue biopsy
|
Organism |
Homo sapiens |
Characteristics |
batch: 1 percent.present: 48.53 scale.factor: 1.07 gapdh.3.5: 3.08 actin.3.5: 10.24 average.correlation: 0.92 qc.flag: FAIL patient identifier: D106 indicator of clinical response (cr=1/pr=2/sd=3): 3 overall survival (years): 1.449539636 status for overall survival (1=death, 0=censored): 1 progression free survival (years): 0.614754098 status for progression free survival (1=death, 0=censored): 1 objective response (1 = cr or pr, 0= sd): 0
|
Extracted molecule |
total RNA |
Extraction protocol |
Qiagen RNeasy Mini Kit
|
Label |
biotin
|
Label protocol |
Prepared samples using the Affymetrix GeneChip ENZO one cycle labeling kit
|
|
|
Hybridization protocol |
Hybridization of samples to Affymetrix GeneChip arrays was performed according to Affymetrix manual instructions
|
Scan protocol |
Scanning of Affymetrix GeneChip arrays was performed according to the Affymerix manual instructions
|
Description |
D106
|
Data processing |
Data is RMA normalized using R/Bioconductor
|
|
|
Submission date |
Apr 11, 2012 |
Last update date |
Apr 25, 2012 |
Contact name |
Miao yu |
E-mail(s) |
miao.yu@duke.edu
|
Organization name |
Duke
|
Street address |
Laselle drive
|
City |
durham |
ZIP/Postal code |
27710 |
Country |
USA |
|
|
Platform ID |
GPL571 |
Series (1) |
GSE37180 |
Gene expression profiles of ovarian tumor biopsies from Phase I dasatinib trial |
|